Fogarty Institutes Prepares for 2016 Lefteroff Interns; Forms Ferolyn Fund Advisory Council
At the Fogarty Institute, we are committed to advancing our mission by teaching and raising the next generation of medtech innovators. That’s why we established the Lefteroff Fund, in honor of Tracy Lefteroff, a remarkable leader and strong proponent for mentoring students who show the curiosity and desire to advance the field; and the Ferolyn Fund, a tribute to Ferolyn Powell’s invaluable contributions to the medical device industry that will benefit innovators who exemplify her spirit.
We are excited to share that we are making strides with both of our programs and welcome your involvement.
Each year, we host 10 students from throughout the United States, Europe and Asia. We introduce them to the extraordinary world of medical technology innovation by offering them the opportunity to shadow and work on projects with our startups and medical technology partners. Through our mentorship program they learn from the best in the industry and receive guidance from industry experts on potential career paths and choices.
Last year alone, our interns gleaned knowledge from industry luminaries such as Hanson Gifford, Managing Partner, the Foundry; Hank Plain, General Partner, Lightstone Ventures; Congresswoman Anna Eshoo; Dr. Vincent Gaudiani, Medical Director of the Norma Melchor Heart & Vascular Institute; Dr. Ken Drazan, head of Johnson & Johnson Innovation; and Mike Mussallem, CEO of Edwards Lifesciences, to name a few.
The 2016 Lefteroff summer intern application process is now open and we need your help as the program depends entirely on charitable donations from generous donors. Please consider contributing today to honor Tracy Lefteroff and to help us mentor and educate the next generation of students, entrepreneurs and innovators who will shape the future of our healthcare.
To learn more about the program, or if you know someone who would be a good candidate, please visit our website. The application deadline is March 20.
The Fogarty Institute recently formed an Advisory Council comprised of a cross-section of community, business and medical leaders who will actively define, support and oversee the mission of the fund, which is to support entrepreneurs with strong leadership skills who embody Ferolyn’s core values.
Ferolyn was best known as President and CEO of Evalve. During her 14-year tenure at Evalve, Ferolyn spearheaded the development and commercialization of MitraClip, a breakthrough technology that repairs leaky heart valves of patients with mitral regurgitation, a debilitating heart condition, without open-heart surgery. One of a handful of women CEOs in her field, she was generous with her time, mentoring young entrepreneurs via the Stanford Biodesign Program and at the Fogarty Institute for Innovation.
The Advisory Council meets twice a year and welcomes your participation. For more information on how to support the next generation of medical technology leaders, please visit our website.